Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-gamma antibody. Mizumaki K, Makino S, Ikawa Y, Maeda S, et al. J Dermatol 2022;49:e311-e312.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mizumaki K, Makino S, Ikawa Y, Maeda S, et al. Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-gamma antibody. J Dermatol 2022;49:e311-e312.
PMID: 35546739